SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications

Solid organ transplant patients are at a higher risk for poor CoronaVirus Disease‐2019 (COVID‐19)‐related outcomes and have been included as a priority group in the vaccination strategy worldwide. We assessed the safety and efficacy of a two‐dose vaccination cycle with mRNA‐based COVID‐19 vaccine (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Gianluca, Lai, Quirino, Poli, Luca, Perrone, Maria Paola, Gaeta, Aurelia, Rossi, Massimo, Mastroianni, Claudio M., Garofalo, Manuela, Pretagostini, Renzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646240/
https://www.ncbi.nlm.nih.gov/pubmed/34569101
http://dx.doi.org/10.1111/ctr.14495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646240/
https://www.ncbi.nlm.nih.gov/pubmed/34569101
http://dx.doi.org/10.1111/ctr.14495

Ejemplares similares